With hard-won gains of the last three months at risk, the ACT-Accelerator has mounted a US$ 7.7 billion appeal, the Rapid ACT-Accelerator Delta Response (RADAR), is needed to fund COVID-19 initiatives:
Is the investment needed to scale up testing to put all low- and lower-middle-income countries on track towards a ten-fold increase in COVID-19 testing and ensure all countries get up to satisfactory testing levels.
US$ 1 billion
Is needed to maintain R&D efforts to stay ahead of the virus by enabling further market shaping and manufacturing, technical assistance and demand generation to ensure that tests, treatments and vaccines remain effective against the Delta variant and other emerging variants, and that they are accessible and affordable where they are needed.
US$ 1.2 billion
Will help rapidly address acute oxygen needs to treat the seriously ill and control the exponential death surges caused by the Delta variant.
US$ 1.4 billion
Needed to help countries identify and address key bottlenecks for the effective deployment and use of all COVID-19 tools.
US$ 1.7 billion
Will protect 2 million frontline healthcare workers with enough basic PPE to keep them safe while they care for the sick, prevent the collapse of health systems where the health workforce is already understaffed and overstretched, and prevent further spread of COVID-19.
Source: The ACT-Accelerator Q2 2021 Update Report from WHO Internation, which provides an overview of the progress made in bringing life-saving COVID-19 tools to countries around the world, and highlights the efforts made to ensure health systems are able to receive and fully optimize the use of COVID-19 countermeasures, It shows how investments made to the ACT-Accelerator have driven results and impact in the fight against COVID-19. https://www.who.int/news/item/16-08-2021-act-accelerator-launches-urgent-appeal-to-stem-surge-of-dangerous-variants-and-save-lives-everywhere